Correction: Clinical benefit and safety of immunotherapy beyond progression in advanced and locally advanced lung cancer: a real-world cohort study - Summary - MDSpire

Correction: Clinical benefit and safety of immunotherapy beyond progression in advanced and locally advanced lung cancer: a real-world cohort study

  • By

  • Frontiers Production Office

  • July 13, 2026

Share

Objective:

To correct the omission of author Hua Lan as an equal contributing author in the original article.

Interpretation:

The original article has been updated to include the correct authorship.

Conclusion:

The correction acknowledges the contributions of all authors involved in the study.

Sources:

Original Source(s)

Correction: Clinical benefit and safety of immunotherapy beyond progression in advanced and locally advanced lung cancer: a real-world cohort study

  • by Frontiers Production Office

  • July 13, 2026

Related Content

Datopotamab deruxtecan in solid tumors: Recent research progress and clinical applications

Predictive modeling for survival-related outcomes in lung cancer patients with brain metastases: a mini-review

A prehabilitation-enhanced nomogram for predicting early pulmonary recovery failure after lung tumor surgery: development and multicenter validation